3.217 USD
+0.03 (+0.85%)
HIND gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 190 industry peers in the Pharmaceuticals industry. The financial health of HIND is average, but there are quite some concerns on its profitability. HIND does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- HIND had negative earnings in the past year.
- HIND had a negative operating cash flow in the past year.
- HIND had negative earnings in each of the past 5 years.
- HIND had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- HIND has a worse Return On Assets (-161.11%) than 87.37% of its industry peers.
- HIND's Return On Equity of -448.70% is on the low side compared to the rest of the industry. HIND is outperformed by 78.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -161.11% | ||
| ROE | -448.7% | ||
| ROIC | N/A |
ROA(3y)-223.45%
ROA(5y)-181.34%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HIND has a better Gross Margin (62.39%) than 72.11% of its industry peers.
- In the last couple of years the Gross Margin of HIND has grown nicely.
- HIND does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.39% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y44.4%
2. Health
2.1 Basic Checks
- HIND does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, HIND has more shares outstanding
- Compared to 5 years ago, HIND has more shares outstanding
- Compared to 1 year ago, HIND has a worse debt to assets ratio.
2.2 Solvency
- HIND has an Altman-Z score of -16.20. This is a bad value and indicates that HIND is not financially healthy and even has some risk of bankruptcy.
- HIND's Altman-Z score of -16.20 is on the low side compared to the rest of the industry. HIND is outperformed by 80.53% of its industry peers.
- There is no outstanding debt for HIND. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -16.2 |
ROIC/WACCN/A
WACC9.35%
2.3 Liquidity
- A Current Ratio of 1.94 indicates that HIND should not have too much problems paying its short term obligations.
- HIND has a Current ratio of 1.94. This is in the lower half of the industry: HIND underperforms 62.63% of its industry peers.
- HIND has a Quick Ratio of 1.94. This is a normal value and indicates that HIND is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of HIND (1.94) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 90.16% over the past year.
- The Revenue for HIND has decreased by -48.74% in the past year. This is quite bad
- The Revenue has been growing by 19.54% on average over the past years. This is quite good.
EPS 1Y (TTM)90.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.02%
Revenue 1Y (TTM)-48.74%
Revenue growth 3Y-16.19%
Revenue growth 5Y19.54%
Sales Q2Q%-98.49%
3.2 Future
- HIND is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -45.64% yearly.
- Based on estimates for the next years, HIND will show a very negative growth in Revenue. The Revenue will decrease by -25.99% on average per year.
EPS Next Y-604.44%
EPS Next 2Y-34.99%
EPS Next 3Y-45.64%
EPS Next 5YN/A
Revenue Next Year-97.51%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- HIND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HIND. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as HIND's earnings are expected to decrease with -45.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-34.99%
EPS Next 3Y-45.64%
5. Dividend
5.1 Amount
- HIND does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
VYOME HOLDINGS INC / HIND FAQ
Can you provide the ChartMill fundamental rating for VYOME HOLDINGS INC?
ChartMill assigns a fundamental rating of 2 / 10 to HIND.
Can you provide the valuation status for VYOME HOLDINGS INC?
ChartMill assigns a valuation rating of 0 / 10 to VYOME HOLDINGS INC (HIND). This can be considered as Overvalued.
What is the profitability of HIND stock?
VYOME HOLDINGS INC (HIND) has a profitability rating of 1 / 10.
What is the financial health of VYOME HOLDINGS INC (HIND) stock?
The financial health rating of VYOME HOLDINGS INC (HIND) is 4 / 10.